This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Clinimix (2015-06-19)
- Starting date:
- June 19, 2015
- Posting date:
- June 22, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-53900
Recalled products
- Clinimix
Reason
Particulate matter found in the solution.
Depth of distribution
Hospital Pharmacy
Affected products
A. Clinimix
DIN, NPN, DIN-HIM
DIN 02046709
Dosage form
Liquid
Strength
- Dextrose - 16.6 g/100 mL
- Glycine - 1040 mg/100 mL
- Histidine - 220 mg/100 mL
- L-Alanine - 1040 mg/100 mL
- L-Arginine - 520 mg/100 mL
- L-Isoleucine - 240 mg/100 mL
- L-Leucine Hydrochloride - 310 mg/100 mL
- L-Lysine Hydrochloride - 290 mg/100 mL
- L-Methionine - 290 mg/100 mL
- L-Phenylalanine Hydrochloride-310 mg/100 mL
- L-Proline - 210 mg/100 mL
- L-Threonine - 210 mg/100 mL
- L-Tyrosine - 20 mg/100 mL
- L-Valine - 230 mg/100 mL
- Tryptophan - 90 mg/100 mL
Lot or serial number
- W4J03C2
- W4J14C1
- W4J14C1S
Companies
- Recalling Firm
-
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA
- Marketing Authorization Holder
-
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA
Related AWRs
